Why the study?
Tricuspid valve endocarditis with recurrent septic pulmonary emboli indicates surgery, but evidence is needed for alternatives like suction filtration and veno-venous bypass in patients who are not ideal surgical candidates.
Does percutaneous extraction using suction filtration and veno-venous bypass improve clinical outcomes in a high-surgical-risk patient with tricuspid valve endocarditis?
Does percutaneous extraction using suction filtration and veno-venous bypass improve clinical outcomes in a high-surgical-risk patient with tricuspid valve endocarditis?
Percutaneous extraction using suction filtration and veno-venous bypass may serve as an effective alternative to open-heart surgery for high-risk patients with tricuspid valve endocarditis.
Single-case success supports feasibility in high-risk tricuspid endocarditis; hypothesis-generating and requires prospective trials before adoption.
Tricuspid valve endocarditis with recurrent septic pulmonary emboli is an indication for surgery. In this report, we present a case of right-sided infective endocarditis (RSIE) in a female patient with a history of intravenous drug use (IVDU). The patient was admitted with multiple chief complaints of fatigue, chills, fever, cough, chest pain, and shortness of breath. She was found to have a large 1.8 cm (W) x 2.4 cm (L) mobile tricuspid valve vegetation on transthoracic echocardiogram (TTE). Despite being on appropriate antibiotics, the patient failed to improve clinically. Cardiothoracic surgery (CTS) evaluated the patient for surgical management of infective endocarditis (IE) given the size of vegetation, persistent bacteremia, and clinical deterioration. However, the risk/benefit ratio for open-heart surgery was high, given the history of active IVDU and hemodynamic instability. The patient underwent percutaneous extraction of the vegetation using suction filtration and veno-venous bypass and her condition significantly improved clinically afterward. We discuss the importance of suction filtration and veno-venous bypass in managing tricuspid valve endocarditis as an alternative in patients who are not ideal candidates for surgery and the need for more evidence regarding its effectiveness compared to surgery.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: